Get the Stockscreener App
19.97
1.38%
-0.28
After Hours:
19.95
-0.02
-0.10%
Catalyst Pharmaceuticals Inc stock is traded at $19.97, with a volume of 1.01M.
It is down -1.38% in the last 24 hours and down -1.82% over the past month.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
See More
Previous Close:
$20.25
Open:
$20.29
24h Volume:
1.01M
Relative Volume:
0.70
Market Cap:
$2.44B
Revenue:
$460.48M
Net Income/Loss:
$142.80M
P/E Ratio:
16.92
EPS:
1.18
Net Cash Flow:
$221.79M
1W Performance:
-1.58%
1M Performance:
-1.82%
6M Performance:
-5.80%
1Y Performance:
-1.58%
1-Day Range:
$19.97
$20.52
1-Week Range:
$19.60
$20.75
52-Week Range:
$19.15
$26.58
Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile
Name
Catalyst Pharmaceuticals Inc
Sector
Industry
Phone
(305) 529-2522
Address
355 ALHAMBRA CIRCLE, CORAL GABLES
Compare CPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPRX
Catalyst Pharmaceuticals Inc
|
19.97 | 2.42B | 460.48M | 142.80M | 221.79M | 1.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-25 | Initiated | Robert W. Baird | Outperform |
| Nov-18-24 | Initiated | Stephens | Overweight |
| Mar-14-24 | Initiated | Citigroup | Buy |
| Mar-07-24 | Initiated | BofA Securities | Buy |
| Dec-21-23 | Initiated | Oppenheimer | Outperform |
| Aug-24-22 | Downgrade | ROTH Capital | Buy → Neutral |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-07-18 | Resumed | Piper Jaffray | Overweight |
| Oct-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Apr-26-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Sep-30-14 | Reiterated | ROTH Capital | Buy |
| Sep-16-14 | Reiterated | ROTH Capital | Buy |
| Sep-15-14 | Reiterated | H.C. Wainwright | Buy |
| Oct-21-13 | Reiterated | Aegis Capital | Buy |
| Sep-24-13 | Initiated | Maxim Group | Buy |
| Sep-06-13 | Reiterated | Aegis Capital | Buy |
| Apr-18-13 | Initiated | Aegis Capital | Buy |
| Aug-27-12 | Upgrade | Rodman & Renshaw | Mkt Perform → Mkt Outperform |
| Oct-01-09 | Upgrade | Merriman | Sell → Neutral |
| May-29-09 | Downgrade | Hapoalim | Neutral → Underperform |
| May-29-09 | Downgrade | Merriman Curhan Ford | Buy → Sell |
| Dec-15-08 | Initiated | Merriman Curhan Ford | Buy |
| Nov-28-07 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Jan-31-07 | Initiated | Stifel Nicolaus | Buy |
| Jan-05-07 | Initiated | First Albany | Buy |
View All
Catalyst Pharmaceuticals Inc Stock (CPRX) Latest News
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Rating of "Buy" by Analysts - MarketBeat
Insider Selling: Catalyst Pharmaceuticals (NASDAQ:CPRX) Insider Sells 30,000 Shares of Stock - MarketBeat
Jacobs Levy Equity Management Inc. Has $12.28 Million Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Advisors Asset Management Inc. Has $4.34 Million Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
21,083 Shares in Catalyst Pharmaceuticals, Inc. $CPRX Purchased by Nomura Holdings Inc. - MarketBeat
Catalyst Pharmaceuticals, Inc. $CPRX Shares Purchased by Clark Capital Management Group Inc. - MarketBeat
New Vernon Capital Holdings II LLC Raises Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Is Catalyst Pharmaceuticals Inc.’s growth already priced inMarket Movement Recap & Long-Term Safe Investment Plans - Lancaster City Council
Is Catalyst Pharmaceuticals Inc. stock a falling knife or bargain buy2025 Macro Impact & Low Risk High Win Rate Stock Picks - Lancaster City Council
Catalyst Pharmaceuticals Settles Firdapse Patent Litigation With Lupin - MSN
Is Catalyst Pharmaceuticals Inc. impacted by rising ratesIndex Update & Verified Momentum Stock Alerts - 뉴스영
State of Wyoming Reduces Stock Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Published on: 2025-09-07 06:18:36 - 뉴스영
What momentum shifts mean for Catalyst Pharmaceuticals Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - Newser
Is Catalyst Pharmaceuticals Inc. gaining market shareBull Run & Free Technical Confirmation Trade Alerts - classian.co.kr
Trexquant Investment LP Increases Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Investors Don't See Light At End Of Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Tunnel - 富途牛牛
Catalyst Pharmaceuticals settles lawsuit with Lupin - MSN
What is the next catalyst for Zentalis Pharmaceuticals Inc.Trade Risk Summary & Verified Momentum Watchlists - خودرو بانک
Can Catalyst Pharmaceuticals Inc. maintain sales growthEarnings Recap Summary & AI Enhanced Trading Signals - خودرو بانک
Is Now a Good Time to Reenter Catalyst Pharmaceuticals Inc.2025 Support & Resistance & Technical Buy Zone Confirmations - beatles.ru
Published on: 2025-09-05 17:12:37 - beatles.ru
Catalyst Pharmaceuticals, Inc. $CPRX Shares Bought by Raymond James Financial Inc. - MarketBeat
Using R and stats models for Catalyst Pharmaceuticals Inc. forecastingQuarterly Portfolio Review & Low Risk High Win Rate Picks - Newser
How high can Catalyst Pharmaceuticals Inc. stock go2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
Catalyst Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Decliners & Community Trade Idea Sharing Platform - Newser
How to recover losses in Catalyst Pharmaceuticals Inc. stockJuly 2025 Sentiment & Expert Curated Trade Ideas - Newser
Catalyst Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Institutional & Real-Time Chart Pattern Alerts - Newser
Smart tools for monitoring Catalyst Pharmaceuticals Inc.’s price actionPortfolio Performance Summary & AI Forecasted Entry/Exit Points - Newser
What is the next catalyst for Mirum Pharmaceuticals Inc.Trade Risk Report & Safe Capital Growth Stock Tips - khodrobank.com
Can Catalyst Pharmaceuticals Inc. outperform in the next rallyMarket Rally & Free Safe Entry Trade Signal Reports - خودرو بانک
Catalyst Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 News Drivers & Expert-Curated Trade Recommendations - Newser
Is Catalyst Pharmaceuticals Inc. reversing from oversold territoryBull Run & Real-Time Chart Breakout Alerts - Newser
News impact scoring models applied to Catalyst Pharmaceuticals Inc.July 2025 PostEarnings & Safe Capital Investment Plans - Newser
Tools to assess Catalyst Pharmaceuticals Inc.’s risk profileTrade Volume Report & Daily Entry Point Alerts - Newser
Detecting support and resistance levels for Catalyst Pharmaceuticals Inc.July 2025 Earnings & Verified High Yield Trade Plans - Newser
Published on: 2025-09-03 23:26:43 - Newser
Statistical indicators supporting Catalyst Pharmaceuticals Inc.’s strengthPortfolio Growth Summary & High Conviction Buy Zone Picks - Newser
How to monitor Catalyst Pharmaceuticals Inc. with trend dashboardsMarket Performance Recap & Daily Technical Stock Forecast Reports - Newser
Risk adjusted return profile for Catalyst Pharmaceuticals Inc. analyzedJuly 2025 Short Interest & Breakout Confirmation Trade Signals - Newser
Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors - 富途牛牛
What is Catalyst Pharmaceuticals Inc. s 5 year growth outlookJuly 2025 Short Interest & Stepwise Swing Trade Plans - beatles.ru
What indicators show strength in Catalyst Pharmaceuticals Inc.July 2025 Drop Watch & Weekly Setup with High ROI Potential - Newser
How to read the order book for Catalyst Pharmaceuticals Inc.Trend Reversal & Safe Entry Momentum Tips - Newser
Should you hold or exit Catalyst Pharmaceuticals Inc. nowSwing Trade & Real-Time Volume Trigger Notifications - Newser
Is it time to cut losses on Catalyst Pharmaceuticals Inc.2025 Market WrapUp & Safe Capital Allocation Plans - Newser
Market reaction to Catalyst Pharmaceuticals Inc.’s recent newsWeekly Profit Report & Daily Chart Pattern Signals - Newser
How is Catalyst Pharmaceuticals Inc. managing supply chain issuesJuly 2025 Setups & Growth Oriented Trade Recommendations - خودرو بانک
Is Catalyst Pharmaceuticals Inc. in a bullish channelJuly 2025 Technicals & AI Powered Market Entry Ideas - خودرو بانک
Catalyst Pharmaceuticals Inc Stock (CPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):